	The Potential for Enhanced Ovarian Cancer Diagnostics Through Optimized Derivative Magnetic Resonance Spectroscopy. Technol Cancer Res Treat Belki, Belki. PMID: 41467364 [PubMed - in process]
	Five things you need to know about prostate cancer diagnostic tests. Asian J Urol Vickers AJ, Lilja H. PMID: 41467205 [PubMed]
	Opportunistic salpingectomy during radical cystectomy for bladder cancer: A systematic review of the literature. Asian J Urol Cerrato C, Pandolfo SD, Kraft P, Ko DSC, Mir MC. PMID: 41467203 [PubMed]
	Prostate cancer screening. Asian J Urol España Navarro R, González-Padilla DA, Subiela JD, Pérez-Serrano C, Olmos D, Carlsson SV. PMID: 41467195 [PubMed]
	Clinically lymph node-positive urothelial bladder cancer treated with upfront radical cystectomy: Diagnostic accuracy of MRI and long-term oncologic outcomes. Asian J Urol Laymon M, Elsawy AA, Elsorougy A, Hashem A, Mosbah A, Abol-Enein H, Mansour I, El-Hefnawy AS. PMID: 41467194 [PubMed]
	Advancements in artificial intelligence for prostate cancer: Optimizing diagnosis, treatment, and prognostic assessment. Asian J Urol Arita Y, Roest C, Kwee TC, Paudyal R, Lema-Dopico A, Fransen S, Hirahara D, Takaya E, Ueda R, Ruby L, Nissan N, Schwartz LH, Shukla-Dave A, Akin O. PMID: 41467190 [PubMed]
	Development and prospective validation of a multitarget urine RNA assay for noninvasive detection of urothelial carcinoma. iScience Xu H, Wang S, Xue D, Xu Z, Zhang Q, Wo Q, Huang B, Mao Z, Liu F, Lou S, Yuan J, Zhu S, Ding L, Wo Y, Luo Z, Chen J, Xu Q, Li G, Qi X, Ye D. PMID: 41467176 [PubMed]
	Identifying potent ABCG2 inhibitors from the COCONUT database of natural compounds to overcome drug resistance in breast cancer: a comprehensive in silico study targeting ATP-binding cassette (ABC) transporter G2. In Silico Pharmacol Mandal P, Barik K, Kumar A, Agarwal S, Singh DV. PMID: 41467166 [PubMed]
	Tumor enhancement by magnetic resonance imaging after endoscopic ultrasound-guided radiofrequency ablation for small pancreatic neuroendocrine tumors. VideoGIE Ardengh AO, Micelli-Neto O, Venco FE, Panizza P, Blasbalg R, Kemp R, Sebastião Dos Santos J, Ardengh JC. PMID: 41467165 [PubMed]
	Peripheral Thermoregulatory Modulation for Hot Flash Management: Efficacy of Novel Wrist Cooling Device in Cancer Treatment-Induced and Menopausal Vasomotor Symptoms. AACE Endocrinol Diabetes Uçar N, Shirvani A, Holick MF. PMID: 41467131 [PubMed]
	Locoregional Considerations for Invasive Lobular Carcinoma. Curr Breast Cancer Rep Mukhtar RA, Flanagan MR. PMID: 41467111 [PubMed]
	Benefit of prophylactic pelvic irradiation in intermediate-risk prostate cancer: A multicenter retrospective study (iPPAPI). Clin Transl Radiat Oncol Raynaud C, Nebbache R, Belkacemi Y, Chargari C, Durdux C, Hennequin C, Huguet F, Quero L, Bibault JE. PMID: 41467108 [PubMed]
	Matrine and Its Derivatives: Multi-Pathway Regulation in Cancer Therapy. Cancer Manag Res Xiong Z, Pu J. PMID: 41467103 [PubMed]
	Prognostic Determinants and Treatment Strategies Associated with Long-Term Survival in Early-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study. J Hepatocell Carcinoma Pan KC, Huang HL, Lu SN, Chang TS. PMID: 41467100 [PubMed]
	Advancing Hepatocellular Carcinoma Therapy with Next-Generation Molecular and Immunotherapeutics. J Hepatocell Carcinoma Hassan M, Hussain I, Ahmad K, Zafar S, Khalid A, Haseeb M, Hussain N, Ghafar MA. PMID: 41467097 [PubMed]
	Comparison of the Efficacy and Safety of Transarterial-Chemoembolization versus Radiofrequency-Ablation for Hepatocellular Carcinoma within Milan Criteria: A Propensity Score-Matching Study. J Hepatocell Carcinoma Tang W, Huang Y, Wang T, Yang J, Zhao Z. PMID: 41467096 [PubMed]
	Delivery of nucleic acid drugs for tumor therapy: Opportunities and challenges. Fundam Res Sun D, Tan W, Zhao J, Tian Y, Li S, Zhang Z, Dong X, Liu X, Liu N, Jiao P, Ma J. PMID: 41467021 [PubMed]
	Heating up the immune battle: Magnetic hyperthermia against cancer. Fundam Res Jiao W, Dai L, Yan B, Lyu Y, Fan H, Liu X. PMID: 41466973 [PubMed]
	Digital Cognitive Behavioral Therapy for Insomnia in Cancer Pain Patients: Protocol for a Prospective, Randomized Controlled Trial. J Pain Res Lan X, Hu X, Lan Z, Wang L, He R, Jiang Z. PMID: 41466871 [PubMed]
	TROPION-Lung15: a randomized phase III study of osimertinib combined with datopotamab deruxtecan (Dato-DXd) or Dato-DXd alone versus platinum-doublet chemotherapy in patients with EGFR-mutated advanced non-small cell lung cancer and whose disease has progressed on prior osimertinib. Ther Adv Med Oncol Tan DS, Nadal E, Cheema P, Wu YL, Ahn MJ, Tanizaki J, Grainger E, Nizialek E, Forcina A, van der Gronde T, Yu HA. PMID: 41466843 [PubMed]

Articles 1 - 20 / 1898318

Page 1 of 94916



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy